Diet-induced Obesity in C57BL/6J Mice Causes Increased Renal Lipid Accumulation and Glomerulosclerosis via a Sterol Regulatory Element-binding Protein-1c-dependent Pathway*
暂无分享,去创建一个
T. Jiang | M. Levi | Zhuowei Wang | S. Liebman | G. Proctor | S. Moskowitz | T. Rogers | M. Lucia | Jinping Li | Shevie Moskowitz
[1] Shuiqing Yu,et al. Diabetes Induces Endothelial Dysfunction but Does Not Increase Neointimal Formation in High-Fat Diet Fed C57BL/6J Mice , 2005, Circulation research.
[2] C. Kahn,et al. Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. , 2005, Diabetes.
[3] Christoph Handschin,et al. Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP , 2005, Cell.
[4] W. Katon,et al. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study. , 2004, Journal of the American Society of Nephrology : JASN.
[5] B. Wisse,et al. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. , 2004, Journal of the American Society of Nephrology : JASN.
[6] Y. Guan. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome. , 2004, Journal of the American Society of Nephrology : JASN.
[7] C. Abrass. Overview: obesity: what does it have to do with kidney disease? , 2004, Journal of the American Society of Nephrology : JASN.
[8] Samy I McFarlane,et al. The relationship between hyperinsulinemia, hypertension and progressive renal disease. , 2004, Journal of the American Society of Nephrology : JASN.
[9] S. Bagby. Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease? , 2004, Journal of the American Society of Nephrology : JASN.
[10] C. Alpers,et al. Original Report: Laboratory Investigation Hyperglycemia and Hyperlipidemia Act Synergistically to Induce Renal Disease in Ldl Receptor-deficient Balb Mice , 2022 .
[11] R. Hammer,et al. Overexpression of Sterol Regulatory Element-binding Protein-1a in Mouse Adipose Tissue Produces Adipocyte Hypertrophy, Increased Fatty Acid Secretion, and Fatty Liver* , 2003, Journal of Biological Chemistry.
[12] H. Vidal,et al. Intramyocitic lipid accumulation and SREBP-1c expression are related to insulin resistance and cardiovascular risk in morbid obesity. , 2003, Atherosclerosis.
[13] R. B. Rawson. The SREBP pathway — insights from insigs and insects , 2003, Nature Reviews Molecular Cell Biology.
[14] M. Simionescu,et al. Saturated-fat diet induces moderate diabetes and severe glomerulosclerosis in hamsters , 2003, Diabetologia.
[15] R. Bigazzi,et al. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] Jukka T Salonen,et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.
[17] J. Xu,et al. Dietary polyunsaturated fats regulate rat liver sterol regulatory element binding proteins-1 and -2 in three distinct stages and by different mechanisms. , 2002, The Journal of nutrition.
[18] C. Trautwein,et al. Insulin and Sterol-regulatory Element-binding Protein-1c (SREBP-1C) Regulation of Gene Expression in 3T3-L1 Adipocytes , 2002, The Journal of Biological Chemistry.
[19] M. Praga. Obesity--a neglected culprit in renal disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[20] C. Marcantoni,et al. Hypertensive nephrosclerosis in African Americans versus Caucasians. , 2002, Kidney international.
[21] H. Shimano,et al. Absence of Sterol Regulatory Element-binding Protein-1 (SREBP-1) Ameliorates Fatty Livers but Not Obesity or Insulin Resistance inLep ob /Lep ob Mice* , 2002, The Journal of Biological Chemistry.
[22] Lijun Sun,et al. Role of Sterol Regulatory Element-binding Protein 1 in Regulation of Renal Lipid Metabolism and Glomerulosclerosis in Diabetes Mellitus* , 2002, The Journal of Biological Chemistry.
[23] R. Hammer,et al. Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice with Selective Deficiency of Sterol Regulatory Element-binding Protein-1c* , 2002, The Journal of Biological Chemistry.
[24] A. Casellas,et al. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. , 2002, Diabetes.
[25] S. Bigler,et al. Functional and structural changes in the kidney in the early stages of obesity. , 2001, Journal of the American Society of Nephrology : JASN.
[26] R. Tilton,et al. Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes Materials and Methods Laboratory Animals , 2022 .
[27] L. Groop,et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.
[28] M. Cooper,et al. Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies. , 2000, Diabetes & metabolism.
[29] H. Gin,et al. Lipids, protein intake, and diabetic nephropathy. , 2000, Diabetes & metabolism.
[30] I. Shimomura,et al. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[31] F. Lammert,et al. Phenotypic characterization of lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice. Pathophysiology Of biliary lipid secretion. , 1999, Journal of lipid research.
[32] M. Rosenfeld,et al. Initiation of Hyperinsulinemia and Hyperleptinemia is Diet Dependent in C57BL/6 Mice , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[33] P. Parekh,et al. Reversal of diet-induced obesity and diabetes in C57BL/6J mice. , 1998, Metabolism: clinical and experimental.
[34] J. Bonventre,et al. Ischemia and Reperfusion Enhance ATF-2 and c-Jun Binding to cAMP Response Elements and to an AP-1 Binding Site from the c-jun Promoter (*) , 1995, The Journal of Biological Chemistry.
[35] H. Schnaper,et al. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. , 1995, Kidney international.
[36] A. Kissebah,et al. Relation of Body Fat Distribution to Metabolic Complications of Obesity , 1982 .
[37] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[38] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.
[39] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[40] R. Virchow,et al. Cellular Pathology, as Based upon Physiological and Pathological Histology , 1860, Nutrition reviews.
[41] B. Kasiske,et al. Effect of lipid reduction on the progression of renal disease: a meta-analysis. , 2001, Kidney international.
[42] V. Kamanna,et al. Role of atherogenic lipoproteins in cytokine-mediated renovascular injury. , 1996, Mineral and electrolyte metabolism.
[43] B. Rovin,et al. LDL stimulates mesangial fibronectin production and chemoattractant expression. , 1993, Kidney international.
[44] P. Kimmelstiel,et al. Intercapillary Lesions in the Glomeruli of the Kidney. , 1936, The American journal of pathology.